nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0549	0.182	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0518	0.172	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0322	0.107	CbGbCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.032	0.066	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0313	0.0644	CrCrCtD
Medroxyprogesterone Acetate—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0296	0.0983	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0296	0.0983	CbGbCtD
Medroxyprogesterone Acetate—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.0264	0.0544	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.0246	0.0506	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0235	0.0485	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.023	0.0473	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0228	0.047	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0227	0.0754	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0224	0.0745	CbGbCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0223	0.0459	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.0221	0.0456	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.0216	0.0445	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.0199	0.0409	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0198	0.0408	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0193	0.0399	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0193	0.0399	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0193	0.0398	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0189	0.0389	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.0184	0.0379	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.018	0.037	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.0172	0.0354	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.0168	0.0346	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0168	0.0346	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0162	0.0333	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0158	0.0325	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0153	0.051	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0146	0.0486	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.013	0.0433	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00765	0.0254	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00723	0.024	CbGbCtD
Medroxyprogesterone Acetate—AKR1C3—bronchus—chronic obstructive pulmonary disease	0.000804	0.0752	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000787	0.0735	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—trachea—chronic obstructive pulmonary disease	0.000722	0.0675	CbGeAlD
Medroxyprogesterone Acetate—PGR—respiratory system—chronic obstructive pulmonary disease	0.000662	0.0619	CbGeAlD
Medroxyprogesterone Acetate—SHBG—connective tissue—chronic obstructive pulmonary disease	0.000647	0.0604	CbGeAlD
Medroxyprogesterone Acetate—PGR—connective tissue—chronic obstructive pulmonary disease	0.000583	0.0544	CbGeAlD
Medroxyprogesterone Acetate—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000533	0.0498	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lung—chronic obstructive pulmonary disease	0.000519	0.0485	CbGeAlD
Medroxyprogesterone Acetate—ESR1—respiratory system—chronic obstructive pulmonary disease	0.000518	0.0484	CbGeAlD
Medroxyprogesterone Acetate—AR—connective tissue—chronic obstructive pulmonary disease	0.000464	0.0434	CbGeAlD
Medroxyprogesterone Acetate—ESR1—connective tissue—chronic obstructive pulmonary disease	0.000456	0.0426	CbGeAlD
Medroxyprogesterone Acetate—AR—bronchus—chronic obstructive pulmonary disease	0.000434	0.0406	CbGeAlD
Medroxyprogesterone Acetate—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000425	0.0397	CbGeAlD
Medroxyprogesterone Acetate—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000417	0.039	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000382	0.0357	CbGeAlD
Medroxyprogesterone Acetate—PGR—lung—chronic obstructive pulmonary disease	0.000351	0.0328	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000336	0.0314	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000314	0.0294	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000308	0.0287	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—trachea—chronic obstructive pulmonary disease	0.000282	0.0264	CbGeAlD
Medroxyprogesterone Acetate—AR—lung—chronic obstructive pulmonary disease	0.00028	0.0262	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lung—chronic obstructive pulmonary disease	0.000275	0.0257	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lung—chronic obstructive pulmonary disease	0.000203	0.019	CbGeAlD
Medroxyprogesterone Acetate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000826	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000823	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000823	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.000816	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00081	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000808	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000808	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000807	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000802	CcSEcCtD
Medroxyprogesterone Acetate—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000799	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000796	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000796	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000791	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000788	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000788	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.000784	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000783	CcSEcCtD
Medroxyprogesterone Acetate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000782	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00078	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000777	CcSEcCtD
Medroxyprogesterone Acetate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000776	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000773	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000769	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000768	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000768	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000759	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.000758	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000752	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000752	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000752	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000749	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000749	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000747	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000744	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000744	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000742	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000742	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000741	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000734	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000107	0.000732	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000728	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000728	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000727	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000727	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000727	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000725	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000718	CcSEcCtD
Medroxyprogesterone Acetate—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000718	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000713	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000712	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00071	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000706	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.000704	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000701	CcSEcCtD
Medroxyprogesterone Acetate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000102	0.0007	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.000698	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.000698	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000692	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0001	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.99e-05	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.000686	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.000681	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.82e-05	0.000675	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000675	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.74e-05	0.00067	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.74e-05	0.00067	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.69e-05	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.69e-05	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.69e-05	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.69e-05	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.66e-05	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Tiotropium—chronic obstructive pulmonary disease	9.58e-05	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.57e-05	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.57e-05	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.54e-05	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.54e-05	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Tiotropium—chronic obstructive pulmonary disease	9.52e-05	0.000654	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000654	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.49e-05	0.000653	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.49e-05	0.000653	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000652	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.47e-05	0.000651	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.39e-05	0.000646	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000644	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.35e-05	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.2e-05	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.15e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.15e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000621	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000621	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.02e-05	0.00062	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.000614	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.85e-05	0.000608	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.8e-05	0.000605	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.8e-05	0.000605	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.67e-05	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.67e-05	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.62e-05	0.000592	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.5e-05	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.39e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.39e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.000571	CcSEcCtD
Medroxyprogesterone Acetate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.22e-05	0.000565	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.19e-05	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisolone—chronic obstructive pulmonary disease	8.14e-05	0.000559	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.11e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.11e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.94e-05	0.000546	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.92e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.8e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.8e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Arformoterol—chronic obstructive pulmonary disease	7.73e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Formoterol—chronic obstructive pulmonary disease	7.73e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.72e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.72e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Formoterol—chronic obstructive pulmonary disease	7.68e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Arformoterol—chronic obstructive pulmonary disease	7.68e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.66e-05	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.64e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Montelukast—chronic obstructive pulmonary disease	7.57e-05	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.56e-05	0.00052	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.55e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Montelukast—chronic obstructive pulmonary disease	7.52e-05	0.000517	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	7.5e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	7.49e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.47e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.43e-05	0.000511	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	7.39e-05	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.36e-05	0.000506	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.34e-05	0.000504	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.000503	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.3e-05	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Salbutamol—chronic obstructive pulmonary disease	7.3e-05	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.29e-05	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.29e-05	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.28e-05	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Formoterol—chronic obstructive pulmonary disease	7.28e-05	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Salbutamol—chronic obstructive pulmonary disease	7.25e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.2e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	7.2e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.15e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Montelukast—chronic obstructive pulmonary disease	7.13e-05	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.05e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.05e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	6.97e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.97e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	6.97e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.88e-05	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.83e-05	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.74e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000459	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.56e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Prednisolone—chronic obstructive pulmonary disease	6.53e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.52e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	6.5e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.48e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.42e-05	0.000441	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	6.33e-05	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	6.23e-05	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	6.21e-05	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	6.21e-05	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	6.18e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000424	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	6.09e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.02e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.01e-05	0.000413	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Prednisone—chronic obstructive pulmonary disease	6e-05	0.000413	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.96e-05	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.93e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.92e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.91e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisone—chronic obstructive pulmonary disease	5.91e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	5.88e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.86e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.81e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.78e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.74e-05	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.67e-05	0.000993	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.67e-05	0.000992	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	5.56e-05	0.000972	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.000967	CbGpPWpGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.49e-05	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.47e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.44e-05	0.000952	CbGpPWpGaD
Medroxyprogesterone Acetate—Agitation—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	5.34e-05	0.000935	CbGpPWpGaD
Medroxyprogesterone Acetate—Malaise—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000367	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.32e-05	0.000931	CbGpPWpGaD
Medroxyprogesterone Acetate—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.000928	CbGpPWpGaD
Medroxyprogesterone Acetate—Syncope—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.27e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.23	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.000917	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.23e-05	0.000916	CbGpPWpGaD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.15e-05	0.000902	CbGpPWpGaD
Medroxyprogesterone Acetate—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.11e-05	0.000895	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	5.09e-05	0.000891	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—CYP1A2—chronic obstructive pulmonary disease	5.08e-05	0.222	CrCbGaD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	5.01e-05	0.000877	CbGpPWpGaD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—CYP1A1—chronic obstructive pulmonary disease	4.98e-05	0.218	CrCbGaD
Medroxyprogesterone Acetate—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.95e-05	0.000867	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.89e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.88e-05	0.000855	CbGpPWpGaD
Medroxyprogesterone Acetate—Oedema—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.82e-05	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—chronic obstructive pulmonary disease	4.78e-05	0.209	CrCbGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.78e-05	0.000837	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.77e-05	0.000834	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000325	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.73e-05	0.000828	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.71e-05	0.000824	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.7e-05	0.000823	CbGpPWpGaD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	4.66e-05	0.000816	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.61e-05	0.000806	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	4.59e-05	0.000803	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.49e-05	0.000786	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.43e-05	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	4.42e-05	0.000773	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.39e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.3e-05	0.000753	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HDAC2—chronic obstructive pulmonary disease	4.3e-05	0.000753	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.3e-05	0.000753	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.00075	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	4.27e-05	0.000747	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.26e-05	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.26e-05	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.000742	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.2e-05	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.18e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisolone—chronic obstructive pulmonary disease	4.16e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.13e-05	0.000722	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.12e-05	0.000721	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	4.04e-05	0.000708	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.03e-05	0.000706	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.03e-05	0.000706	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KL—chronic obstructive pulmonary disease	4e-05	0.0007	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.98e-05	0.000696	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.95e-05	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.95e-05	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.94e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.92e-05	0.000686	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.92e-05	0.000686	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.92e-05	0.000686	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.000677	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.78e-05	0.000662	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.74e-05	0.000654	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.71e-05	0.00065	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	3.71e-05	0.00065	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.65e-05	0.00064	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.000639	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.64e-05	0.000637	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.6e-05	0.000631	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.6e-05	0.000629	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.57e-05	0.000625	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALB—chronic obstructive pulmonary disease	3.56e-05	0.000623	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.56e-05	0.000623	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.53e-05	0.000617	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.5e-05	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	3.47e-05	0.000607	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000606	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.42e-05	0.000599	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.42e-05	0.000598	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.41e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.41e-05	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.36e-05	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.3e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.28e-05	0.000574	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	3.26e-05	0.000571	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.25e-05	0.000569	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.19e-05	0.000558	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.14e-05	0.00055	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.12e-05	0.000546	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000543	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000211	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.02e-05	0.000528	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.01e-05	0.000527	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ERBB3—chronic obstructive pulmonary disease	3e-05	0.000525	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3e-05	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.99e-05	0.000523	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.96e-05	0.000518	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.000513	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.83e-05	0.000495	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.8e-05	0.00049	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.8e-05	0.000489	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.79e-05	0.000488	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.78e-05	0.000487	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—ALB—chronic obstructive pulmonary disease	2.78e-05	0.121	CrCbGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.77e-05	0.000485	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.75e-05	0.000482	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000478	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.72e-05	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.62e-05	0.000459	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000453	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.59e-05	0.000453	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.59e-05	0.000453	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.000452	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2.51e-05	0.000439	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS2—chronic obstructive pulmonary disease	2.5e-05	0.000437	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.44e-05	0.000427	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000423	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.41e-05	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000416	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.38e-05	0.000416	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.37e-05	0.000414	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.3e-05	0.000403	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.28e-05	0.000399	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.27e-05	0.000397	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000397	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000394	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.000394	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.21e-05	0.000387	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.21e-05	0.000386	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.18e-05	0.000381	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.15e-05	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.15e-05	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.11e-05	0.00037	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SERPINE1—chronic obstructive pulmonary disease	2.1e-05	0.000368	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.1e-05	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.000359	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.04e-05	0.000357	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.000354	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS3—chronic obstructive pulmonary disease	2.01e-05	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000348	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.91e-05	0.000334	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.88e-05	0.000329	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.85e-05	0.000323	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.84e-05	0.000322	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.00032	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.82e-05	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.79e-05	0.000313	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000308	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000295	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.67e-05	0.000292	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.66e-05	0.00029	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.000279	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.48e-05	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.41e-05	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.39e-05	0.000244	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.36e-05	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.3e-05	0.000227	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000218	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.22e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.2e-05	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.18e-05	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.16e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.13e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.1e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.00019	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.05e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—chronic obstructive pulmonary disease	1e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.85e-06	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.81e-06	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.72e-06	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.7e-06	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.35e-06	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.31e-06	0.000163	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.12e-06	0.00016	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.04e-06	0.000158	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.91e-06	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.85e-06	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.7e-06	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.35e-06	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.24e-06	0.000144	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.15e-06	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8e-06	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.68e-06	0.000134	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.66e-06	0.000134	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.34e-06	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.28e-06	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.2e-06	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.01e-06	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.82e-06	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.8e-06	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.71e-06	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.52e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.47e-06	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.39e-06	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.25e-06	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.04e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.92e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.84e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.78e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.53e-06	9.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.38e-06	9.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.23e-06	9.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.95e-06	8.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-06	8.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.69e-06	8.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.48e-06	7.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.42e-06	7.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.31e-06	7.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.22e-06	7.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.12e-06	7.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.03e-06	7.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.91e-06	6.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	6.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.55e-06	6.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.25e-06	5.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.66e-06	4.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.54e-06	4.44e-05	CbGpPWpGaD
